AOS files Chapter 11, will continue to represent interests of ODs

Article

The American Optometric Society (AOS) has filed for Chapter 11 bankruptcy and confirms it will continue to operate.

 

Los Angeles-The American Optometric Society (AOS) has confirmed that it will continue to operate as the professional optometric organization representing the individual optometrist.

Following the AOS vs. American Board of Optometry (ABO) lawsuit, the organization has received widespread encouragement from both members and non-members alike, according to the AOS.

In order to continue its mission, the AOS has chosen to seek protection under Chapter 11 of the U.S. Bankruptcy Code. The AOS will operate no differently, in principle, both in identifying significant issues in the profession and supporting organized optometry, at the state and national level.

The AOS will continue to mobilize a broad base of support to bring about positive change and prevent our profession from being damaged and divided.

Also, the AOS that will hold its 4th Annual CE Symposium April 12-14 at the Westin Riverwalk in San Antonio; the 3rd annual Harvey Yamamoto Student Scholarship will be awarded at that time. Early bird registration continues through Jan. 31.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
© 2025 MJH Life Sciences

All rights reserved.